KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Invested Capital (2016 - 2026)

Johnson & Johnson's Invested Capital history spans 18 years, with the latest figure at $98.6 billion for Q1 2026.

  • On a quarterly basis, Invested Capital rose 7.22% to $98.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $98.6 billion, a 7.22% increase, with the full-year FY2025 number at $123.0 billion, up 18.38% from a year prior.
  • Invested Capital hit $98.6 billion in Q1 2026 for Johnson & Johnson, down from $123.0 billion in the prior quarter.
  • Over the last five years, Invested Capital for JNJ hit a ceiling of $123.0 billion in Q4 2025 and a floor of $74.6 billion in Q3 2024.
  • Historically, Invested Capital has averaged $90.3 billion across 5 years, with a median of $88.5 billion in 2023.
  • Biggest five-year swings in Invested Capital: decreased 11.57% in 2024 and later increased 18.38% in 2025.
  • Tracing JNJ's Invested Capital over 5 years: stood at $79.0 billion in 2022, then rose by 21.64% to $96.1 billion in 2023, then rose by 8.08% to $103.9 billion in 2024, then rose by 18.38% to $123.0 billion in 2025, then dropped by 19.79% to $98.6 billion in 2026.
  • Business Quant data shows Invested Capital for JNJ at $98.6 billion in Q1 2026, $123.0 billion in Q4 2025, and $85.7 billion in Q3 2025.